Alector (ALEC) EV to FCF (2019 - 2026)
Alector's (ALEC) quarterly EV to FCF came in at 1.51 in Q2 2026, down 144.66% year-over-year from 3.38 in Q2 2025, and down 133.85% quarter-over-quarter from 0.64 in Q1 2026.
Analysis
Alector (ALEC) EV to FCF (2019 - 2026) Analysis & Trends
Alector (ALEC) has reported EV to FCF for 8 consecutive years, with 1.51 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to FCF fell 144.66% year-over-year to 1.51 in Q2 2026; TTM through Jun 2026 was 0.33, a 142.52% decrease from a year earlier, with the FY2025 full-year figure at 0.46, down 53.43% from the prior year.
- EV to FCF was 1.51 for Q2 2026 at Alector, down from 0.64 in the prior quarter.
- Over five years, EV to FCF peaked at 4.1 in Q4 2024 and troughed at 2.77 in Q4 2023.
- A 5-year average of 0.86 and a median of 0.48 in 2023 frame the typical range for EV to FCF.
- The widest YoY moves for EV to FCF: up 1398.24% in 2025, down 5071.13% in 2025.
- Over 5 years, EV to FCF stood at 1.05 in 2022, then plunged by 163.75% to 2.77 in 2023, then jumped by 247.63% to 4.1 in 2024, then slumped by 50.9% to 2.01 in 2025, then tumbled by 174.95% to 1.51 in 2026.
- The last three EV to FCF figures came in at 1.51 (Q2 2026), 0.64 (Q1 2026), and 2.01 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.51 |
| Mar 31, 2026 | -0.64 |
| Dec 31, 2025 | 2.01 |
| Sep 30, 2025 | -0.83 |
| Jun 30, 2025 | 3.38 |
| Mar 31, 2025 | 3.81 |
| Dec 31, 2024 | 4.10 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.97 |
| Mar 31, 2024 | -0.29 |
| Dec 31, 2023 | -2.77 |
| Sep 30, 2023 | 0.94 |
| Jun 30, 2023 | 2.85 |
| Mar 31, 2023 | 3.09 |
| Dec 31, 2022 | -1.05 |
| Sep 30, 2022 | -0.34 |
| Jun 30, 2022 | -0.41 |
| Mar 31, 2022 | 2.23 |
| Dec 31, 2021 | -19.22 |
| Sep 30, 2021 | 2.32 |